Goodwill and Other Intangibles (Tables)

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of changes in the carrying amount of goodwill

Changes in the carrying amount of our goodwill for the six months ended June 30, 2019 were as follows (in thousands):

	Branded Pharmaceuticals		Sterile Injectables		Generic Pharmaceuticals			International Pharmaceuticals		Total
Goodwill as of December 31, 2018	$	828,818	$	2,731,193	$	151,108		$	53,517	$	3,764,636
Effect of currency translation	—		—		—			2,169		2,169
Goodwill impairment charges	—		—		(151,108		)	—		(151,108		)
Goodwill as of June 30, 2019	$	828,818	$	2,731,193	$	—		$	55,686	$	3,615,697

The carrying amounts of goodwill at June 30, 2019 and December 31, 2018 are net of the following accumulated impairments (in thousands):

	Branded Pharmaceuticals		Sterile Injectables		Generic Pharmaceuticals		International Pharmaceuticals		Total
Accumulated impairment losses as of December 31, 2018	$	855,810	$	—	$	2,991,549	$	456,408	$	4,303,767
Accumulated impairment losses as of June 30, 2019	$	855,810	$	—	$	3,142,657	$	475,416	$	4,473,883

Schedule of other intangible assets

Changes in the amount of other intangible assets for the six months ended June 30, 2019 are set forth in the table below (in thousands).

Cost basis:	Balance as of December 31, 2018			Acquisitions			Impairments			Other (1)			Effect of Currency Translation			Balance as of June 30, 2019
Indefinite-lived intangibles:
In-process research and development	$	93,900		$	—		$	—		$	—		$	—		$	93,900
Total indefinite-lived intangibles	$	93,900		$	—		$	—		$	—		$	—		$	93,900
Finite-lived intangibles:
Licenses (weighted average life of 14 years)	$	457,402		$	—		$	—		$	—		$	—		$	457,402
Tradenames	6,409			—			—			—			—			6,409
Developed technology (weighted average life of 11 years)	6,182,015			—			(100,399		)	(1,179		)	10,273			6,090,710
Total finite-lived intangibles (weighted average life of 11 years)	$	6,645,826		$	—		$	(100,399	)	$	(1,179	)	$	10,273		$	6,554,521
Total other intangibles	$	6,739,726		$	—		$	(100,399	)	$	(1,179	)	$	10,273		$	6,648,421
Accumulated amortization:	Balance as of December 31, 2018			Amortization			Impairments			Other (1)			Effect of Currency Translation			Balance as of June 30, 2019
Finite-lived intangibles:
Licenses	$	(398,182	)	$	(7,298	)	$	—		$	—		$	—		$	(405,480	)
Tradenames	(6,409		)	—			—			—			—			(6,409		)
Developed technology	(2,877,829		)	(278,719		)	—			1,179			(5,509		)	(3,160,878		)
Total other intangibles	$	(3,282,420	)	$	(286,017	)	$	—		$	1,179		$	(5,509	)	$	(3,572,767	)
Net other intangibles	$	3,457,306														$	3,075,654

__________

(1)

Other adjustments relate to the removal of certain fully amortized intangible assets.

Schedule of future amortization expense

Estimated amortization of intangibles for the five fiscal years subsequent to December 31, 2018 is as follows (in thousands):

2019	$	544,094
2020	$	458,449
2021	$	416,495
2022	$	400,592
2023	$	370,298

Schedule of intangible asset impairment charges including goodwill

During the three and six months ended June 30, 2019 and 2018, the Company incurred the following goodwill and other intangible asset impairment charges (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Goodwill impairment charges	$	65,108	$	—	$	151,108	$	391,000
Other intangible asset impairment charges	$	21,699	$	22,767	$	100,399	$	76,967